Medications

Study finds drug beneficial for shrinking mesothelioma tumors

A drug that is designed to boost the immune system against mesothelioma, when combined with immunotherapy, was found to be beneficial in a small study involving ten patients. The results, which appeared July 1, 2020, in Science ...

Psychology & Psychiatry

Impressive result for mental health therapy

The researchers evaluated the NewAccess program, which is an Australian adaptation of the United Kingdom's IAPT (Improving Access to Psychological Therapies) approach of delivering low intensity therapies for symptoms of ...

Diseases, Conditions, Syndromes

Age, CRP up risk for mortality in diabetes with COVID-19

(HealthDay)—For patients with diabetes and COVID-19, risk factors for mortality include older age and elevated C-reactive protein, and insulin usage is associated with poor prognosis, according to a study published online ...

Diseases, Conditions, Syndromes

Addition of zinc may benefit some being treated for COVID-19

(HealthDay)—For hospitalized patients with COVID-19, the addition of zinc sulfate to hydroxychloroquine and azithromycin may improve some outcomes, according to a study not yet peer reviewed and posted on medRxiv.org.

Medical research

Patients improve after heart cell therapy

Four of six critically ill COVID-19 (coronavirus) patients significantly improved after receiving an experimental therapeutic designed to reduce inflammation, a major cause of death from this disease, according to a case ...

page 1 from 33